SCHEMBL7510387

SCHEMBL7510387

CCCCNc1nc(Sc2ccccc2)nc2c1nnn2C1C[C@H](C(N)=O)C(O)C1O

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ P2RY12 Q9H244 18/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7510382 1.00 P2RY12 (0.77) P2RY12
SCHEMBL7516058 0.94 P2RY12 (0.77) P2RY12
SCHEMBL7516050 0.94 P2RY12 (0.77) P2RY12
SCHEMBL7507158 0.90 P2RY12 (0.72) P2RY12
SCHEMBL7507169 0.90 P2RY12 (0.72) P2RY12
SCHEMBL7511758 0.88 P2RY12 (0.72) P2RY12
SCHEMBL7511751 0.88 P2RY12 (0.72) P2RY12
SCHEMBL7507767 0.87 P2RY12 (1.00) P2RY12
SCHEMBL7507777 0.87 P2RY12 (1.00) P2RY12
SCHEMBL7505466 0.87 P2RY12 (0.73) P2RY12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946561-B1 TRIAZOLO(4,5-D)PYRIMIDINYL DERIVATIVES AND THEIR USE AS MEDICAMENTS ASTRAZENECA AB (SE) 2002-02-13 — — EP claimed
US-6297232-B1 TREATMENT OF PLATELET AGGREGATION DISORDERS. ASTRAZENECA AB (SE) 2001-10-02 — — US claimed
EP-0946561-B1 TRIAZOLO(4,5-D)PYRIMIDINYL DERIVATIVES AND THEIR USE AS MEDICAMENTS ASTRAZENECA AB (SE) 2002-02-13 — — EP disclosed
US-6297232-B1 TREATMENT OF PLATELET AGGREGATION DISORDERS. ASTRAZENECA AB (SE) 2001-10-02 — — US disclosed
Send feedback